نتایج جستجو برای: atorvastatin calcium

تعداد نتایج: 172112  

Journal: :Clinical pharmacology and therapeutics 1998
T Kantola K T Kivistö P J Neuvonen

BACKGROUND Itraconazole, a potent inhibitor of CYP3A4, increases the risk of skeletal muscle toxicity of some 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors by increasing their serum concentrations. The aim of this study was to characterize the effect of itraconazole on the pharmacokinetics of atorvastatin, a new HMG-CoA reductase inhibitor that is metabolized at least in ...

2015
Yu Jin Chunguang Qiu Qiangsun Zheng Ling Liu Zhiqiang Liu Yi Wang

OBJECTIVE To compare the efficacy of 40 mg and l0 mg atorvastatin on serum levels of 8-Hydroxy-Guanin (8-OHdG) and the cardiac function in patients with ischemic cardiomyopathy (ICM). METHODS One hundred twenty three hospitalized ICM patients and 120 healthy controls were included in this study. All subjects were randomly divided into two groups: 10 mg/d atorvastatin group (n=62) and 40 mg/d ...

2018
Jun-Hui Chen Ting Wu Li-Kun Yang Lei Chen Jie Zhu Pei-Pei Li Xu Hu Yu-Hai Wang

The aim of the present study was to assess the therapeutic effects of atorvastatin on cerebral vessel autoregulation and to explore the underlying mechanisms in a rabbit model of subarachnoid hemorrhage (SAH). A total of 48 healthy male New Zealand rabbits (weight, 2‑2.5 kg) were randomly allocated into SAH, Sham or SAH + atorvastatin groups (n=16/group). The Sham group received 20 mg/kg/d sali...

Journal: :Neurology 2012
E Waubant D Pelletier M Mass J A Cohen M Kita A Cross A Bar-Or T Vollmer M Racke O Stüve S Schwid A Goodman N Kachuck J Preiningerova B Weinstock-Guttman P A Calabresi A Miller M Mokhtarani D Iklé S Murphy H Kopetskie L Ding E Rosenberg C Spencer S S Zamvil

OBJECTIVE To test efficacy and safety of atorvastatin in subjects with clinically isolated syndrome (CIS). METHODS Subjects with CIS were enrolled in a phase II, double-blind, placebo-controlled, 14-center randomized trial testing 80 mg atorvastatin on clinical and brain MRI activity. Brain MRIs were performed quarterly. The primary endpoint (PEP) was development of ≥ 3 new T2 lesions, or one...

Journal: :American journal of physiology. Heart and circulatory physiology 2012
Arturo Giordano Simona Romano Mario Monaco Antonio Sorrentino Nicola Corcione Anna Laura Di Pace Paolo Ferraro Giovanna Nappo Michele Polimeno Maria Fiammetta Romano

Although considered promising for use in drug-eluting stents (DES), tacrolimus failed clinically. Tacrolimus inhibits growth factor production but can also act as a growth factor on vascular smooth muscle cells (VSMC). This unexpected proliferative stimulus could reverse the beneficial effects of the drug on restenosis. We hypothesized that tacrolimus' association with statins, which lower chol...

Journal: :European heart journal 2010
Luigi Marzio Biasucci Italo Porto

The search for potent and efficacious inhibitors of the enzyme HMG-CoA reductase (HMGRIs) has long been the focus of considerable research. Atorvastatin calcium, one of the first synthetically designed HMGRIs, was created in 1985 and, due to a large number of trials showing positive clinical effect, especially in the field of acute coronary syndromes (ACS), has since obtained a leading role in ...

2011
Yunes Panahi Bahram Pishgoo Fatemeh Beiraghdar Zahra Mohammadi Araghi Amirhossein Sahebkar Ehsan Abolhasani

The present study evaluated the potential benefit of supplementation with Heracleumpersicum as an adjunctive therapy to atorvastatin in dyslipidemic subjects. In a randomized, open-label, clinical trial, 100 dyslipidemic subjects were randomly assigned to: (1) H. persicum group (n=50, completers=18), receiving H. persicum extract (500 mg/day) + atorvastatin (10 mg/day) for 8 weeks, or (2) atorv...

Ali Ghazavi Fardin Faraji Ghasem Mosayebi, Keyvan Ghasami Masoud Fazeli

Background: Statins, widely used cholesterol-lowering agents, have also been demonstrated to have anti-inflammatory and immunomdulatory effects. Objective: To evaluate the effects of atorvastatin in combination with Interferon-β in the treatment of multiple sclerosis (MS) in a randomized controlled clinical trial. Methods: Multiple sclerosis patients were randomized independently, in a double b...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2002
Sven Wassmann Ulrich Laufs Kirsten Müller Christian Konkol Katja Ahlbory Anselm T Bäumer Wolfgang Linz Michael Böhm Georg Nickenig

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) may exert direct effects on vascular cells and beneficially influence endothelial dysfunction. Because reactive oxygen species (ROS) may lead to vascular damage and dysfunction, we investigated the effect of atorvastatin on ROS production and the underlying mechanisms in vitro and in vivo. Cultured rat aortic vascular smooth m...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004
Kosaku Nitta Takashi Akiba Hiroshi Nihei

Vascular calcification is believed to have a crucial role in the excess cardiovascular mortality and morbidity in patients with end-stage renal disease (ESRD). Recent evidence suggests that uraemic vascular calcification is an active cellmediated process [1]. An epidemiological study observed an association between lipid-lowering therapy and vascular calcification [2]. However, no prospective i...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید